Dolly Good

Ron James, managing director of PPL and the closest thing Dolly has to a father, got his start at New Zealand-spawned pharmo-giant Glaxo. Now PPL is using New Zealand cows in research aiming to produce drugs to treat multiple sclerosis.


Tags: cloning  Dolly the sheep  GlaxoSmithKline  Guardian (The)  multiple sclerosis  New Zealand  NZ cows  Pon James  PPL  

Launch Market Leaders Rocket Lab Count Down

Launch Market Leaders Rocket Lab Count Down

New Zealand-founded Rocket Lab stock is ready for take-off, according to US investment bank and financial services company, Cowen. Carmen Reinicke reports for CNBC. The firm recently upgraded shares of the company…